2025
2024
Grants from Bill & Melinda Gates Foundation
René Holm has received USD 1.024.500 from the Bill & Melinda Gates Foundation to conduct an extensive investigation into factors stabilizing suspensions in co-operation with Monash University in Melbourne.
René Holm has received USD 100.000 from the Bill & Melinda Gates Foundation to conduct an extensive preformulation study of Levonorgestrel and to investigate the supplier variations.
2023
Project to Improve Tuberculosis treatment through Drug Delivery
René Holm has received a grant of USD 1.25 million from the Bill & Melinda Gates Foundation for investigating the possibility of developing long-acting injectable formulations using three different substances against tuberculosis. The project focuses on injection suspensions and the determination of proper stabilization of the suspensions, as well as their particle size, in order to achieve a release period of 4-6 months for the three substances. This would optimize the treatment, particularly in regions of the world with limited access to healthcare systems.
Grant from Janssen Pharmaceutical
René Holm has received Euro 412,500 to investigate optimization of drug absorption into the eye when dosed in different drug forms applied topical, as well as for research into how these formulations are preserved with minimal use of preservatives. The money has been granted by Janssen Pharmaceutica, Belgium, that is also the main cooperator on the project .
2022
Grant from the Carlsberg Foundation
Annette Bauer-Brandl has received DKK 771.557 from the Carlsberg Foundation for research infrastructure for the project "Multichannel fiber optic monitor for real time concentration measurement".
Grant from the Independent Research Fund Denmark
Carsten Uhd Nielsen has received DKK 2.875.680 from the Independent Research Fund Denmark, Nature and Universe for the project "Rational search for inhibitors of amino acid transporters: Implications for targeting transporters as prostate cancer treatment".
2021
Grant from Innovationsfonden
Poul Nielsen, FKF, Christoffer V. Heidtmann, FKF, Janne Kudsk Klitgaard, BMB, Carsten Uhd Nielsen, FKF and Thomas M. Clemmensen, SDU-RIO, have recieved DKK 1.484.640 from Innovationsfonden for the project "A novel antibiotic for the fight against multiresistant bacteria".
Grant from Independent Research Fund Denmark
Jacob Kongsted, Poul Nielsen and Carsten Uhd Nielsen have received a grant from Independent Research Fund Denmark, DKK 3.273.120, for the project “P-glycoprotein inhibition from a molecular basis – development of rational design strategies for P-glycoprotein modulators”.
Grant from the Novo Nordisk Foundation
René Holm has received a Start Package grant from the Novo Nordisk Foundation, DKK 6.500.000, for setting up his research group at the department.
2020
Grant from the Novo Nordisk Foundation
Jacob Kongsted and Carsten Uhd Nielsen have received a grant from the Novo Nordisk Foundation, DKK 2.454.900, for the project “Understanding P-glycoprotein inhibition from a molecular basis – development of rational design strategies for P-glycoprotein inhibitors”.
EUFunding
The research group including Annette Bauer-Brandl, Martin Brandle and Paul Stein is one of the partners participating in the new project: Eliminating animals from the development of new oral drug formulations: EU funds MSCA-H2020 EID InPharma. The EU-funded InPharma project is working towards making drug development more predictable and reducing animal testing in drug development by using a fully integra¬ted, animal-free, end-to-end modelling approach to the formulation of drugs for oral administration.